Pages that link to "Q52301412"
Jump to navigation
Jump to search
The following pages link to Euphorigenic drugs: effects on the reward pathways of the brain (Q52301412):
Displaying 50 items.
- Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats (Q24647023) (← links)
- Neurocircuitry of addiction (Q24647156) (← links)
- The "stop" and "go" of nicotine dependence: role of GABA and glutamate (Q26824406) (← links)
- Mechanistic insights into nicotine withdrawal (Q27687645) (← links)
- Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs (Q28080974) (← links)
- Glutamatergic transmission in drug reward: implications for drug addiction (Q28112161) (← links)
- The central amygdala as an integrative hub for anxiety and alcohol use disorders (Q30383734) (← links)
- Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake (Q30387433) (← links)
- Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia (Q30413012) (← links)
- Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice (Q30463322) (← links)
- Deficit in brain reward function and acute and protracted anxiety-like behavior after discontinuation of a chronic alcohol liquid diet in rats (Q30474802) (← links)
- Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats (Q30476918) (← links)
- Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice (Q30489401) (← links)
- Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine. (Q30491416) (← links)
- Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats (Q30738165) (← links)
- Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine. (Q30830275) (← links)
- Comorbidity of substance abuse with other psychiatric disorders (Q33285122) (← links)
- Hedonic Homeostatic Dysregulation as a Driver of Drug-Seeking Behavior (Q33572392) (← links)
- Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse (Q33656596) (← links)
- The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats (Q33693262) (← links)
- Self-administered heroin and cocaine combinations in the rat: additive reinforcing effects-supra-additive effects on nucleus accumbens extracellular dopamine (Q33722801) (← links)
- Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand (Q33815047) (← links)
- Neurobiology of dysregulated motivational systems in drug addiction (Q33915824) (← links)
- Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats (Q33921387) (← links)
- Decreased brain reward produced by ethanol withdrawal (Q34161433) (← links)
- Individual differences in prefrontal cortex function and the transition from drug use to drug dependence (Q34203887) (← links)
- Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior (Q34245006) (← links)
- Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex (Q34378202) (← links)
- Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats (Q34696292) (← links)
- Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats (Q34709317) (← links)
- Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats (Q35027648) (← links)
- Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice (Q35054656) (← links)
- Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation. (Q35110020) (← links)
- The anti-(+)-methamphetamine monoclonal antibody mAb7F9 attenuates acute (+)-methamphetamine effects on intracranial self-stimulation in rats (Q35151502) (← links)
- The dark side of emotion: the addiction perspective (Q35235813) (← links)
- Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats (Q35291239) (← links)
- Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues (Q35538485) (← links)
- Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence (Q35623042) (← links)
- Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats (Q35647607) (← links)
- Differential Modulation of Thresholds for Intracranial Self-Stimulation by mGlu5 Positive and Negative Allosteric Modulators: Implications for Effects on Drug Self-Administration. (Q35657336) (← links)
- Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems (Q35783139) (← links)
- Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice (Q35831006) (← links)
- Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats (Q35859810) (← links)
- Effects of nicotine and minor tobacco alkaloids on intracranial-self-stimulation in rats. (Q35875970) (← links)
- Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats (Q35913833) (← links)
- Diet-induced obesity and diet-resistant rats: differences in the rewarding and anorectic effects of D-amphetamine (Q35952342) (← links)
- Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement-attenuating and discriminative stimulus effects in rats (Q35997407) (← links)
- Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats (Q36021414) (← links)
- Pituitary adenylate cyclase-activating polypeptide induces a depressive-like phenotype in rats. (Q36047912) (← links)
- Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. (Q36110661) (← links)